Tetravalent enterovirus vaccine safety and effectiveness study
Part of Infections clinical trials.
This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 71 months (about 6 years) old
- Your child must be in good health with no serious chronic illnesses
- Your child cannot have had hand, foot, and mouth disease before
- Your child cannot have received certain vaccines within the past 1–2 weeks
- You must be able to attend all study visits and follow the study schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.
This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
Hear when a new Hand, Foot, and Mouth Disease(HFMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.